Agenus
Develops investigational BOT+BAL antibodies for colorectal cancer and selected tumors.
$7.66
After-hours close0.00 (0.00%)
At close$7.66(−1.92%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.02 | — | — |
| Aug 2026 | $0.05 | −$0.01 | −122.2% |
| May 2026 | $2.10 | $1.02 | −51.4% |
| Mar 2026 | −$1.27 | $0.56 | +144.1% |
| Nov 2025 | $2.63 | $1.94 | −26.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Mar 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | $0.02 | — | — | $35.0M | — | — |
| Aug 6, 2026 | $0.05 | −$0.01 | −122.2% | $34.0M | $34.5M | +1.5% |
| May 11, 2026 | $2.10 | $1.02 | −51.4% | $129.5M | $33.7M | −74.0% |
| Mar 16, 2026 | −$1.27 | $0.56 | +144.1% | $28.1M | $34.2M | +21.7% |
| Nov 10, 2025 | $2.63 | $1.94 | −26.2% | $28.1M | $30.2M | +7.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 11, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 7, 2024 | ||||||
| Mar 14, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 14, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 15, 2021 | ||||||
| Oct 29, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 4, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 10, 2019 | ||||||
| Mar 14, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 9, 2018 | ||||||
| May 7, 2018 | ||||||
| Mar 15, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 3, 2017 | ||||||
| May 4, 2017 | ||||||
| Mar 9, 2017 | ||||||
| Oct 27, 2016 | ||||||
| Jul 28, 2016 | ||||||
| Apr 28, 2016 | ||||||
| Mar 3, 2016 | ||||||
| Oct 27, 2015 | ||||||
| Jul 23, 2015 | ||||||